OpenBilldrug price receipt

NADAC week of 2026-10-14

TOBRADEX ST 0.3-0.05% EYE DROP

FDA nonproprietary name: tobramycin / dexamethasone

For 5 mL

Pharmacies pay

$233.16 filed

5 × $46.63243 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$232.23 filed

5 × $46.44643 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.0× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Tobradex St” / “Tobramycin/Dexamethasone” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$273.13 estimated

$233.16 + $34.97 (15%) + $5.00 fee per fill = $273.13

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TOBRADEX ST 0.3-0.05% EYE DROP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as tobramycin / dexamethasone, under the trade name “Tobradex ST”.

FDA gives its dosage form as suspension/ drops and its route as ophthalmic.

Its labelers, the companies named on the label, are Eyevance Pharmaceuticals, LLC and Harrow Eye, LLC.

FDA lists it under 2 Established Pharmacologic Classes: Aminoglycoside Antibacterial and Corticosteroid.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $233.16 for 5 mL (5 × $46.63243 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

All 2 NDCs

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $46.63243 per ML filed.

Of the 15 other products in FDA’s Aminoglycoside Antibacterial class priced per ML, 1 has a higher middle NADAC price and 14 a lower one. The one in the middle is NEOMYCIN-POLYMYXIN-HC EAR SUSP, at $3.83312 per ML filed (eff. 2026-09-23).

Of the 106 other products in FDA’s Corticosteroid class priced per ML, 3 have a higher middle NADAC price and 103 a lower one. The one in the middle is FLUNISOLIDE 0.025% SPRAY, at $1.98777 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $232.23 for 5 mL, at an average of $46.44643 per ML in 2024 (2024-01-01 to 2024-12-31) for “Tobradex St” and “Tobramycin/Dexamethasone”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 24,550 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for TOBRADEX ST 0.3-0.05% EYE DROP labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Tobradex St / Tobramycin/Dexamethasone: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
Why does this page start at 5 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 5 mL in one package for all 2 NDCs of this product (“1 BOTTLE, DROPPER in 1 CARTON (71776-035-05) / 5 mL in 1 BOTTLE, DROPPER”), so the card starts at one package: 5 ML. Change it to match your prescription.